ATE322687T1 - Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 - Google Patents

Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1

Info

Publication number
ATE322687T1
ATE322687T1 AT00966291T AT00966291T ATE322687T1 AT E322687 T1 ATE322687 T1 AT E322687T1 AT 00966291 T AT00966291 T AT 00966291T AT 00966291 T AT00966291 T AT 00966291T AT E322687 T1 ATE322687 T1 AT E322687T1
Authority
AT
Austria
Prior art keywords
psa
ratio
igf
prostate cancer
determining
Prior art date
Application number
AT00966291T
Other languages
English (en)
Inventor
Keith Griffiths
Atilla T Turkes
Original Assignee
Joken Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923599.6A external-priority patent/GB9923599D0/en
Priority claimed from GB0012869A external-priority patent/GB0012869D0/en
Application filed by Joken Ltd filed Critical Joken Ltd
Application granted granted Critical
Publication of ATE322687T1 publication Critical patent/ATE322687T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00966291T 1999-10-07 2000-10-09 Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 ATE322687T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923599.6A GB9923599D0 (en) 1999-10-07 1999-10-07 Assay
GB0012869A GB0012869D0 (en) 2000-05-27 2000-05-27 Assay

Publications (1)

Publication Number Publication Date
ATE322687T1 true ATE322687T1 (de) 2006-04-15

Family

ID=26244366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966291T ATE322687T1 (de) 1999-10-07 2000-10-09 Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1

Country Status (8)

Country Link
EP (1) EP1218749B1 (de)
AT (1) ATE322687T1 (de)
AU (1) AU781669B2 (de)
CA (1) CA2388706A1 (de)
DE (1) DE60027176T2 (de)
ES (1) ES2259290T3 (de)
PT (1) PT1218749E (de)
WO (1) WO2001025790A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
GB0503741D0 (en) * 2005-02-23 2005-03-30 Eden Research Plc Assay
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
EP2757731B1 (de) 2013-01-21 2015-02-18 Fujitsu Limited Drahtloses MIMO-Kommunikationssystem
CN106932570A (zh) * 2017-03-07 2017-07-07 中国人民解放军第二军医大学 一种检测前列腺特异性抗原psa的试剂盒及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
NZ506091A (en) * 1998-01-21 2003-07-25 Brigham & Womens Hospital Circulating insulin-like growth factor-i and prostate cancer risk

Also Published As

Publication number Publication date
AU781669B2 (en) 2005-06-02
AU7673600A (en) 2001-05-10
CA2388706A1 (en) 2001-04-12
EP1218749B1 (de) 2006-04-05
EP1218749A1 (de) 2002-07-03
DE60027176T2 (de) 2007-03-08
WO2001025790A1 (en) 2001-04-12
DE60027176D1 (de) 2006-05-18
ES2259290T3 (es) 2006-10-01
PT1218749E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
SE0000538D0 (sv) Methods and kits for proximity probing
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
ATE539816T1 (de) Verfahren zum diagnostischen testen
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
AU6775201A (en) Improved capture and detection of target nucleic acid in dipstick assays
CN103890585A (zh) 电化学测定
ATE384952T1 (de) Enzymhemmungsimmunverfahren
WO2003100006A3 (en) Method of improved prostate cancer detection
ATE369564T1 (de) Differenzielles immunoassay für myoglobin
WO2005073405A3 (en) Catalytic polynucleotide and its use for determination of analytes
ATE322687T1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
ATE330225T1 (de) Verfahren und testkit zum nachweis von analyten in einer probe
CA2361000A1 (en) Urinary trypsin inhibitor to diagnose aids
CA2434694A1 (en) Detection and quantification of cripto-1
WO2001084161A3 (en) Process for the measurement of non-transferrin bound iron
EP1441224A3 (de) Enzymhemmungsimmunverfahren
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
WO2002004122A3 (en) Improved stability of hybridisation interactions in dipstick assays
DE60038557D1 (en) Assay
WO2002014869A3 (en) Assay method and device for detecting the presence and concentration of analytes
TW200502399A (en) Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren
CA2530479A1 (en) Use of protein proteasome activator subunit 3 (pse3) as a marker for colorectal cancer
DK1200826T3 (da) Immunoassay og testanordning med integreret reference

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1218749

Country of ref document: EP

REN Ceased due to non-payment of the annual fee